Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation: Afatinib in Biomarker-Selected TumorsEunice L Kwak,Geoffrey I Shapiro,Seth M Cohen, Carlos R Becerra,Heinzjosef Lenz,Wenfang Cheng,Wuchou Su,Meghan Robohn,Florence Le Maulf,Maximilian T Lobmeyer,Vikram K Chand,A John IafrateCancer(2013)引用 26|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要